Navigation Links
InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet™ (Pirfenidone) in Europe
Date:12/17/2010

n the European headquarters in Basel, Switzerland and has worked in Switzerland, the UK, the US and Italy.  The following executives will report to Mr. Di Nepi.
  • Senior Vice President, EU Medical and Global Medical Advisor – Frank T. Weber, M.D.   Dr. Weber has 20 years of industry experience, having served most recently as Chief Medical Officer at Merck Serono where he played a key role in the registration and reimbursement processes in Europe for Erbitux® (cetuximab).  Dr. Weber previously served in various medical affairs positions at American Cyanamid/Lederle, Sythelabo and Merck KGaA.  He also worked on the national reimbursement side as Medical Director with MedNet, a Munich Re/United Health Care joint venture.  Dr. Weber began his career in healthcare as a surgeon and immunologist.  Dr. Weber has worked in Germany, Switzerland, France, the UK and the United States.  He will be based in the European headquarters in Basel, Switzerland.
  • Senior Vice President and General Manager, Germany – Markus Leyck Dieken, M.D. Dr. Dieken joins InterMune from Novartis, where he was Head of the European Region for the vaccines business and Managing Director of Novartis-Behring's German operations.  Prior to Novartis, he served for 10 years with Novo Nordisk Germany in various roles in Medical Affairs, Marketing and Sales, and then as General Manager of the German subsidiary and Vice President, Central Europe.  He has worked in Germany and Switzerland.  Dr. Leyck Dieken will be based in Berlin, Germany.  
  • Vice President, Sales and Marketing, Europe – Ms. Manuela Maronati.  Ms. Maronati brings 15 years of sales and marketing experience, including the past seven years with Amgen where she served as an International Senior Marketing Manager on the Neupogen® (filgrastim) franchise, and where she previously launched a new medical device f
    '/>"/>

    • SOURCE InterMune, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. InterMune to Release Third Quarter Financial Results on October 28
    2. InterMune Sells Danoprevir Rights to Roche for $175 Million
    3. InterMune to Present at 2010 Citi Health Care Conference
    4. InterMune Receives FDA Complete Response Letter on Esbriet(TM) (Pirfenidone) New Drug Application
    5. InterMune to Release First Quarter Financial Results on April 29
    6. InterMune Announces Submission of MAA for Pirfenidone for the Treatment of Patients With IPF
    7. InterMune Announces Proposed Public Offering of Common Stock
    8. InterMune to Release Third Quarter Financial Results on November 5
    9. InterMune Announces Collaboration With National Jewish Health on NIH-Supported Genetic Research in Idiopathic Pulmonary Fibrosis
    10. InterMune to Present at Canaccord Adams Conference
    11. InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/24/2013)... May 24, 2013 Quincy Bioscience, ... and development of calcium-binding proteins to support healthy ... safety assessment study of apoaequorin in ... published for the British Industrial Biological Research Association. ... to investigate potential adverse effects, if any, of ...
    (Date:5/23/2013)... 23, 2013 Venaxis, Inc. (Nasdaq:   APPY), ... obtaining FDA clearance and commercializing its rapid, protein biomarker-based ... of an underwritten public offering of 10,000,000 shares of ... shares of its common stock at an exercise price ... price of $1.25 per share and related warrant.  Venaxis ...
    (Date:5/23/2013)... May 23, 2013 Graphite Metallizing ... self-lubricating bushings mounted in stainless steel pillow blocks. ... of GRAPHALLOY with the application and installation versatility ... Pillow Blocks work exceptionally well when submerged ... hostile liquids such as acids, alkalies, hydrocarbons, black ...
    (Date:5/23/2013)... Ind. , May 23, 2013  Rahal Letterman ... in human cord blood stem cell banking and therapeutics, ... of the No. 16 Acorn Stairlifts Indy car driven ... for the remainder of the IZOD IndyCar 2013 season. ... (RLL) will work to support awareness of umbilical cord ...
    Breaking Biology Technology:Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3
    ... by leading international cardiology societiesTOKYO and INDIANAPOLIS, May ... 38 study applied the new classification system for ... results of the study and showed that patients ... intervention (PCI) and taking prasugrel, as compared with ...
    ... ,Agendia, a world leader in molecular cancer diagnostics, today ... California San Francisco ,and the Netherlands Cancer Institute will ... Clinical Oncology Annual Meeting, May 29 - June 2,2009, ... study results further underpin the broad predictive and prognostic,power ...
    ... VIENNA, Austria, May 21 EUCODIS Bioscience, a ... for the,chemical industry, announced today that it has ... of Danisco. Under the terms of the,agreement, EUCODIS ... vivo recombination" to the development of an optimized,version ...
    Cached Biology Technology:Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 2Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 3Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 4Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 5Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 6Agendia to Present Multiple Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO Annual Meeting 2Agendia to Present Multiple Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO Annual Meeting 3EUCODIS Bioscience Signs Research Agreement With Genencor 2
    (Date:5/23/2013)... Investigators at Rollins School of Public Health at ... Institute of Technology, have received a $4 million ... Center at Emory University (Health and Exposome Research ... first exposome-based center grant awarded in the United ... by the National Institute of Environmental Health Sciences ...
    (Date:5/23/2013)... (May 23, 2013) A new report from the ... helping pupils engage in at least 60 minutes of ... , No more than half of American youth meet ... vigorous or moderate intensity physical activity daily, according to ... children are in school for nearly half of their ...
    (Date:5/23/2013)... an age when microbial pathogens are growing increasingly resistant ... a team of Wisconsin scientists has synthesized a potent ... that cause staph infections. , Writing online in the ... group led by University of Wisconsin-Madison chemistry Professor Helen ... sensing" behavior of Staphylococcus aureus , a bacterium ...
    Breaking Biology News(10 mins):Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3Schools should provide students with daily physical activity, IOM recommends 2University of Wisconsin chemists find new compounds to curb staph infection 2
    ... South African scientists working at the epicenter of the ... human immunodeficiency virus (HIV) "exhausts" killer T cells that ... HIV can simply "turn off" fully functional T cells ... test tube studies, however, the scientists showed that they ...
    ... a deadly fish virus detected in the northeastern United States ... probably spread to at least two more. But they have ... death of hundreds of fish in Lake Ontario and the ... month, Cornell's Aquatic Animal Health Program at the College of ...
    ... ever done finds that the big cats reside in 40 ... ago. The tigers now occupy only 7 percent of ... commissioned by the National Fish & Wildlife Foundation's Save The ... tiger scientists at World Wildlife Fund, Wildlife Conservation Society, the ...
    Cached Biology News:How HIV 'exhausts' killer T cells 2How HIV 'exhausts' killer T cells 3How HIV 'exhausts' killer T cells 4Fish virus in Northeast spreading to other fish species 2New tiger report release: Tiger habitat down from just a decade ago 2
    ... Mung Bean Nuclease catalyzes the degradation of ... 5-phosphoryl terminated products. While the nuclease prefers ... high concentrations the enzyme degrades double-stranded DNA ... has been used for transcript mapping studies ...
    Trop-2 Purified Anti-Human clone 162-46, Isotype Mouse IgG 1 , 100 µg Consult technical datasheet for details....
    ... is used in conjunction with ... of problematic and/or GC-rich templates ... with 10X PCRX Amplification Buffer ... magnesium concentration broader annealing temperature ...
    ... ZMD.473. Immunogen: Synthetic peptide derived ... mouse junctophilin-2. Specificity: Specific for ... (positive controls: mouse skeletal muscle homogenates ... Applications: Western blotting Immunohistochemistry(froz) ImmunofluorescenceStorage: Store ...
    Biology Products: